Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

by Milne Katy, Alexander Cheryl, Webb John R, Sun Winnie, Dillon Kristy, Kalloger Steve E, Gilks C Blake, Clarke Blaise, Köbel Martin, Nelson Brad H
Published 2012-02-01

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

by Swenerton Kenneth D, Kalloger Steve E, Köbel Martin, Adamiak Anna, Ronnett Bridgett M, Vang Russell, Wiegand Kimberly C, McAlpine Jessica N, Huntsman David G, Gilks C, Miller Dianne M
Published 2009-12-01

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

by Mehl Erika, Kenney Challayne, Santos Jennifer L, McKinney Steven, Köbel Martin, Kalloger Steve, Klausen Christian, Prentice Leah M, Gilks C Blake, Leung Peter, Swenerton Ken, Huntsman David G, Aparicio Samuel AJ
Published 2007-11-01

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

by Miller Dianne M, Wang Yuker, Spellman Paul T, Smith Margaret, Blood Katherine A, Kalloger Steve E, Kaurah Pardeep, Ridge Yolanda, Troussard Armelle, Young Sean, Boyd Niki, De Luca Alessandro, Press Joshua Z, Horsman Doug, Faham Malek, Gilks C Blake, Gray Joe, Huntsman David G
Published 2008-01-01